-
-
-
-
-
-
-
Xeris Biopharma exchanges $23 million in convertible notes for cash and stock
-
-
-
-
-
-
-
Xeris sues generic drugmakers over Recorlev patents
-
-
-
-
-
-
-
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
-
-
-
-
-
-
-
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
-
-
-
-
-
-
-
Xeris Biopharma Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 1c
-
1,231,056 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


